Pacira BioSciences (PCRX) Operating Leases (2019 - 2026)
Pacira BioSciences (PCRX) recorded Operating Leases of $38.7 million in Q2 2026, down 6.3% from $41.29 million a year earlier but up 14.8% from the prior quarter.
Pacira BioSciences (PCRX) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Pacira BioSciences reported Operating Leases of $36.18 million, down 19.0% from FY2024.
- Annual Operating Leases has declined for four straight years, with a five-year compound annual growth rate of -12.6% (FY2020 to FY2025).
- Across earlier years, Operating Leases came in at $44.65 million in FY2024 (-18.5%), $54.81 million in FY2023 (-15.4%), $64.8 million in FY2022 (-9.7%) and $71.73 million in FY2021 (+1.0%).
- Quarterly Operating Leases has ranged from $33.71 million in Q1 2026 to $71.73 million in Q4 2021 over the past five years.
- On a year-over-year basis, Operating Leases has declined for 17 consecutive quarters, with an average decline of 17.0% over the last eight quarters.
- Peak year-over-year performance for Operating Leases in the last five years was growth of 1.0% in Q4 2021, against a decline of 22.8% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $33.71 million (Q1 2026), $36.18 million (Q4 2025) and $38.84 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Pacira BioSciences | 1.01 Bn | 73.12 Mn | 148.24 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 38.70 Mn |
| Mar 31, 2026 | 33.71 Mn |
| Dec 31, 2025 | 36.18 Mn |
| Sep 30, 2025 | 38.84 Mn |
| Jun 30, 2025 | 41.29 Mn |
| Mar 31, 2025 | 43.68 Mn |
| Dec 31, 2024 | 44.65 Mn |
| Sep 30, 2024 | 47.88 Mn |
| Jun 30, 2024 | 50.15 Mn |
| Mar 31, 2024 | 52.45 Mn |
| Dec 31, 2023 | 54.81 Mn |
| Sep 30, 2023 | 57.09 Mn |
| Jun 30, 2023 | 60.05 Mn |
| Mar 31, 2023 | 62.44 Mn |
| Dec 31, 2022 | 64.80 Mn |
| Sep 30, 2022 | 65.40 Mn |
| Jun 30, 2022 | 67.58 Mn |
| Mar 31, 2022 | 69.71 Mn |
| Dec 31, 2021 | 71.73 Mn |
| Sep 30, 2021 | 66.78 Mn |
Pacira BioSciences Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=PCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();